Prospects and modalities for the treatment of genetic ocular anomalies
Over the last three decades, genetic studies have made great strides toward the identification of genes and genetic mechanisms underlying congenital disorders of the eye. However, despite the vast knowledge available this has not translated into treatments to prevent or repair the damage in the clinical setting. Recently, new research in technologies, such as tissue regeneration, next generation designer drugs, and genome editing, have become available for some genetic disorders that might be applicable to congenital ocular diseases in the near future. Here, we provide an overview of the emerging therapeutic modalities and the future prospects they hold for debilitating ocular defects.
Compliance with ethical standards
Conflict of interest
The authors declare there is no conflict of interest.
- Allergan and Editas Medicine enter into strategic R&D alliance to discover and develop CRISPR genome editing medicines for eye diseases. Allergan Press Releases; 2017; March 14, 2017. https://www.allergan.com/news/news/thomson-reuters/allergan-and-editas-medicine-enter-into-strategic
- Burnight ER, Giacalone JC, Cooke JA, Thompson JR, Bohrer LR, Chirco KR et al (2018) CRISPR-Cas9 genome engineering: treating inherited retinal degeneration. Prog Retin Eye Res Mar 22, https://doi.org/10.1016/j.preteyeres.2018.03.003
- Lawrence JM, Singhal S, Bhatia B et al (2007) MIO-M1 cells and similar Muller glial cell lines derived from adult. Hum Retina Exhib Neural Stem Cell Charact Stem Cells 25:2033–2043Google Scholar
- Lillien L (1994) Neurogenesis in the vertebrate retina. Perspect Dev Neurobiol 2:172–182Google Scholar
- Lust K, Wittbrodt J (2018) Activating the regenerative potential of Müller glia cells in a regeneration-deficient retina. Elife Jan 29;7 https://doi.org/10.7554/eLife.32319
- Martin-del-Campo R, Barcenas-Ibarra A, Sifuentes-Romero I, Llera-Herrera R, Garcia-Gasca A (2018) Methylation status of the putative Pax6 promoter in olive ridley sea turtle embryos with eye defects: an initial approach. Mech Dev. https://doi.org/10.1016/j.mod.2018.08.005. [Epub ahead of print]Google Scholar
- Neuhaus C, Eisenberger T, Decker C, Nagl S, Blank C, Pfister M et al (2017) Next-generation sequencing reveals the mutational landscape of clinically diagnosed Usher syndrome: copy number variations, phenocopies, a predominant target for translational read-through, and PEX26 mutated in Heimler syndrome. Mol Genet Genomic Med 5:531–552CrossRefGoogle Scholar
- Rhan RI, O’Keefe M, Kenny D, Nolan L (2007) Changing pattern of childhood blindness. Ir Med J 100:458–461Google Scholar